Pamela Stephenson

Filings by Pamela Stephenson span 3 companies, the busiest being Albireo Pharma, Inc., Zynerba Pharmaceuticals, Inc. and Disc Medicine, Inc. The record holds 38 filings, for trades running from 25 March 2019 to 17 February 2026.

On the market, this insider has only sold: 24 sales, €716k in total. Outside the open market, there are 11 share grants. 2026 to date brings no purchases and 1 sale.

The latest filing, published on 17 February 2026, reports an open-market sale of €293k in Disc Medicine, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.